Developer docs
API playgroundTry for free, no card

Search company profiles

Envy Medical, Inc.

Full company profile

uuid000vckk

Namestring
Envy Medical, Inc.
Websiteurl
envymedical.com
Company typeenum
Private
Founded yearint
2002
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLong Beach, United States
HQ citystring
Long Beach
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical aesthetics products, dermatology solutions, biotech aesthetics, professional skincare, skin health treatments
Industry1 code
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Services-Health Services8000
Product category
Medical Aesthetics
No data
Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Envy Medical is a biotechnology company that develops and provides dermatology and medical aesthetics solutions for the professional skincare market. The company operates in the medical aesthetics industry, offering biotechnology-based products designed for dermatological and aesthetic applications.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Dermatology and Medical Aesthetics Solutions
CategoryMedical Aesthetics
Description

Biotechnology-based dermatology and medical aesthetics products offered by Envy Medical to the professional skincare and aesthetics market.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

European-headquartered dermatology-focused specialty pharma with medical aesthetics exposure. Comparable in dermatology franchise focus but operates primarily outside the U.S. market.

TypeDirect peer
Description

Aesthetic device company offering energy-based systems for skin, body, and hair treatments. Comparable in the device-based aesthetics category that overlaps with Envy Medical's aesthetic device offerings.

TypeEmerging player
Description

Aesthetics-focused biopharmaceutical company commercializing injectable neurotoxins. Comparable as a focused, smaller-scale competitor in medical aesthetics competing against large incumbents.

TypeDirect peer
Description

Global dermatology-focused pharmaceutical company with a portfolio of prescription and aesthetic skincare products. Direct competitor to Envy Medical in dermatology and medical aesthetics, with overlapping physician channels and product categories.

TypeDirect peer
Description

Specialty aesthetics company offering injectables, devices, and skincare. Operates in the same dermatology/medical aesthetics category as Envy Medical with comparable physician-channel GTM motion.

TypeDirect peer
Description

Specialty professional skincare brand sold through medical aesthetics providers. Closely comparable in channel (physician/med-spa), product category, and target customer to Envy Medical.

TypeBroad incumbent
Description

The aesthetics arm of AbbVie (post-Allergan acquisition) is the dominant incumbent in medical aesthetics, offering injectables, skincare, and body contouring. Broad incumbent competing with Envy Medical across multiple aesthetics categories with vastly greater scale.

TypeDirect peer
Description

Physician-dispensed skincare and dermatology brand focused on transformation and anti-aging. Comparable to Envy Medical in physician-channel skincare distribution and dermatology positioning.

TypeDirect peer
Description

Professional-grade skincare brand sold through physicians and med-spas, now part of AbbVie's aesthetics portfolio. Highly comparable in product positioning, channel strategy, and customer base to Envy Medical's skincare offerings.

TypeBroad incumbent
Description

Diversified specialty pharma with a meaningful dermatology franchise (including ortho-dermatologic and aesthetics assets). Broad incumbent with overlapping dermatology positioning.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Envy Medical, Inc.

Medical Aestheticsenvymedical.com

Envy Medical, Inc. firmographics

Firmographics
Name
Envy Medical, Inc.
Website
https://envymedical.com
Company type
Private
Founded year
2002
Headcount range
101–250 employees
Ownership category
akta.pro rank

Envy Medical, Inc. industry classification

Industry
Product category
Medical Aesthetics
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Medical aesthetics products
  • Dermatology solutions
  • Biotech aesthetics
  • Professional skincare
  • Skin health treatments

Where Envy Medical, Inc. is headquartered

Location

Headquarters

HQ city
Long Beach
HQ country
United States
HQ region
North America

Markets served

Envy Medical, Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Envy Medical, Inc. product offering

Product offering

Core offering

Envy Medical is a biotechnology company that develops and provides dermatology and medical aesthetics solutions for the professional skincare market. The company operates in the medical aesthetics industry, offering biotechnology-based products designed for dermatological and aesthetic applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dermatology and Medical Aesthetics Solutions Biotechnology-based dermatology and medical aesthetics products offered by Envy Medical to the professional skincare and aesthetics market.

Companies that use Envy Medical, Inc.

Customer profile

Ideal customer profiles1 record

Envy Medical, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Envy Medical, Inc. partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

Envy Medical, Inc. competitors and assessment

Company assessment

Regional players

  • Almirall: European-headquartered dermatology-focused specialty pharma with medical aesthetics exposure. Comparable in dermatology franchise focus but operates primarily outside the U.S. market.

Direct peers

  • Cutera: Aesthetic device company offering energy-based systems for skin, body, and hair treatments. Comparable in the device-based aesthetics category that overlaps with Envy Medical's aesthetic device offerings.
  • Galderma: Global dermatology-focused pharmaceutical company with a portfolio of prescription and aesthetic skincare products. Direct competitor to Envy Medical in dermatology and medical aesthetics, with overlapping physician channels and product categories.
  • Merz Aesthetics: Specialty aesthetics company offering injectables, devices, and skincare. Operates in the same dermatology/medical aesthetics category as Envy Medical with comparable physician-channel GTM motion.
  • Revision Skincare: Specialty professional skincare brand sold through medical aesthetics providers. Closely comparable in channel (physician/med-spa), product category, and target customer to Envy Medical.
  • Obagi Medical: Physician-dispensed skincare and dermatology brand focused on transformation and anti-aging. Comparable to Envy Medical in physician-channel skincare distribution and dermatology positioning.
  • SkinMedica (Allergan/AbbVie): Professional-grade skincare brand sold through physicians and med-spas, now part of AbbVie's aesthetics portfolio. Highly comparable in product positioning, channel strategy, and customer base to Envy Medical's skincare offerings.

Emerging players

  • Evolus: Aesthetics-focused biopharmaceutical company commercializing injectable neurotoxins. Comparable as a focused, smaller-scale competitor in medical aesthetics competing against large incumbents.

Broad incumbents

  • Allergan Aesthetics (AbbVie): The aesthetics arm of AbbVie (post-Allergan acquisition) is the dominant incumbent in medical aesthetics, offering injectables, skincare, and body contouring. Broad incumbent competing with Envy Medical across multiple aesthetics categories with vastly greater scale.
  • Bausch Health (Dermatology): Diversified specialty pharma with a meaningful dermatology franchise (including ortho-dermatologic and aesthetics assets). Broad incumbent with overlapping dermatology positioning.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

Envy Medical, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Envy Medical, Inc. leadership team

Management profile

Number of profiles

Envy Medical, Inc. funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Envy Medical, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Envy Medical, Inc.

What does Envy Medical, Inc. do?

Envy Medical is a biotechnology company that develops and provides dermatology and medical aesthetics solutions for the professional skincare market. The company operates in the medical aesthetics industry, offering biotechnology-based products designed for dermatological and aesthetic applications.

When was Envy Medical, Inc. founded?

Envy Medical, Inc. was founded in 2002. It employs 101 to 250 people.

Where is Envy Medical, Inc. based?

Envy Medical, Inc. is headquartered in Long Beach, United States, in the North America region.

Who are Envy Medical, Inc.'s main competitors?

Almirall is listed as a regional player. Direct peers are Cutera, Galderma, Merz Aesthetics, Revision Skincare, Obagi Medical and SkinMedica (Allergan/AbbVie). Evolus is listed as an emerging player. Broad incumbents are Allergan Aesthetics (AbbVie) and Bausch Health (Dermatology).

Does Envy Medical, Inc. have an API?

No public API is recorded for Envy Medical, Inc..

What industry is Envy Medical, Inc. in?

Envy Medical, Inc.'s product category is Medical Aesthetics. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 3391 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlobal Acne Drugs (Salicylic acid, Retin-A Micro, Onexton, and Solodyn) Market Report 2020ResearchAndMarkets.com published the 'Acne Drugs Global Market Report 2020,' which values the global acne drugs market at approximately $15.45 billion in 2018, projecting growth to $20.48 billion by 2022 at a 7.3% CAGR. The report identifies rising disposable incomes as a key growth driver, with combination therapy emerging as an industry trend, while noting regulatory headwinds including India's CDSCO warning on isotretinoin safety. In March 2019, Allergan acquired Envy Medical Inc. to strengthen its position in the acne and skincare market.PR NewswireEnvy Medical Introduces Transformative SkincareEnvy Medical, a Long Beach, California-based skincare company, introduced a new range of eight skincare formulations targeting age-related concerns including hyperpigmentation, dullness, sagging skin, and fine lines. The products incorporate patented ingredient technologies, including the Lumixyl Peptide developed by Stanford University, and are segmented into four offerings: Daily Skin Health Maintenance, Skin Brightening, Intensive Skin Brightening, and Skin Brightening & Renewal. The company aimed to maintain its professional reputation while appealing to a broader consumer audience through updated formulas and packaging.PR NewswireSilkPeel® Dermalinfusion® Packs 3-In-1 PunchEnvy Medical is promoting its SilkPeel Dermalinfusion treatment, a non-invasive skin-resurfacing procedure that combines exfoliation, extraction, and serum infusion to address concerns like hyperpigmentation and aging. The treatment is priced between $150 and $250 and is available at select medical offices, medspas, and spas across the United States.PR NewswireEnvy Medical Appoints Sona Tolani As Senior Vice President Of MarketingEnvy Medical, Inc. announced the appointment of Sona Tolani as Senior Vice President of Marketing, a newly created role at the dermatology and medical aesthetics company based in Westlake Village, California. Tolani joins from Dermalogica (a Unilever brand) where she spent nearly a decade as Senior Director of Global Marketing, bringing over 15 years of beauty industry experience. In her new role, she will lead marketing strategy for the company's portfolio brands including ClarityMD, SilkPeel, and Lumixyl, with a focus on expanding global retail penetration across physician and consumer channels.PR NewswireEnvy Medical Launches SilkPeel® Daily Dermal OptimizerEnvy Medical, Inc. announced the launch of SilkPeel Daily Dermal Optimizer, a new at-home skincare product designed to extend the benefits of their in-office SilkPeel Diamond Dermalinfusion treatment, launching at the AAD conference in Washington, DC on March 4, 2016. The product contains the company's patented Activ8 peptide complex along with ingredients like Allantoin and Bakuchiol, retails for $120, and is positioned as a protective aftercare lotion for post-procedure use. Envy Medical, a developer of non-invasive skin rejuvenation therapies, states the launch addresses customer demand for gentle hydrating aftercare that optimizes in-office treatment outcomes.PR NewswireEnvy Medical Expands SilkPeel® Offering With Four New Skin-Perfecting InitiativesEnvy Medical, Inc. announced four additions to its SilkPeel Diamond Dermalinfusion product line: a redesigned website, an Ultra Hydrating Pro-Infusion Solution, Epiplane medical-grade treatment heads for sensitive skin, and a Daily Dermal Optimizer for at-home use. The products will launch at the American Academy of Dermatology annual meeting on March 4-8, 2016, in Washington, DC. The expansion aims to broaden the SilkPeel's appeal to a wider range of skincare needs while providing aftercare options to extend treatment results.PR NewswireEnvy Medical, Inc. Appoints Arash A. Khazei As Chief Executive OfficerEnvy Medical, Inc. appointed Arash A. Khazei as its new Chief Executive Officer, replacing Curtis A. Cluff who resigned after seven years to pursue other business opportunities. Khazei joins from L'Oreal, where he served as Senior Vice President managing NYX Cosmetics following its 2014 acquisition, and previously held CFO roles at NYX and United PanAm Financial Corporation. The company, which develops non-invasive skin rejuvenation therapies including the SilkPeel system, stated that Khazei's experience in scaling global brands will support its next phase of international expansion.